Temporal evolution of vasospasm and clinical outcome after intra-arterial vasodilator therapy in patients with aneurysmal subarachnoid hemorrhage.
Intra-arterial (IA) vasodilator therapy is one of the recommended treatments to minimize the impact of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm refractory to standard management. However, its usefulness and efficacy is not well established. We evaluated the effect IA vasodilator...
Main Authors: | Laleh Daftari Besheli, Can Ozan Tan, Donnie L Bell, Joshua A Hirsch, Rajiv Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5365119?pdf=render |
Similar Items
-
Intra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage
by: A. Chiriac, et al.
Published: (2016-12-01) -
Hyponatremia as predictor of symptomatic vasospasm in aneurysmal subarachnoid hemorrhage
by: Faisal Alabbas, et al.
Published: (2020-12-01) -
Management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage
by: Mohamed Shehabeldin, et al.
Published: (2017-07-01) -
Clinical Prediction of Symptomatic Vasospasm in Aneurysmal Subarachnoid Hemorrhage
by: Lee, Hubert
Published: (2017) -
Vasospasm following aneurysmal subarachnoid hemorrhage: Thrombocytopenia a marker
by: Ashish Aggarwal, et al.
Published: (2013-07-01)